Skip to main content

Table 1 Characteristics of the BASE-II participants included in the present study

From: T cell phenotypes associated with insulin resistance: results from the Berlin Aging Study II

  Men (n = 181) Women (n = 256)
Age [years] 70 (67–73) 68 (66–70)
BMI [NR 18–25 kg/m2] 26.9 (25.0–29.0) 25.8 (23.4–28.6)
Body weight [kg] 82.1 (76.4–90.5) 68.0 (62.0–76.3)
Height [cm] 175.7 (171.0–180.0) 163.2 (158.9–168)
HbA1c [NR < 5.7%] 5.5 (5.2–5.7) 5.4 (5.2–5.7)
HOMA-IR (NR < 1.9) 2.0 (1.4–3.0) 1.7 (1.2–2.5)
ISIOGTT (NR > 4)a 5.6 (3.3–8.7) 5.7 (3.8–8.3)
Fasting PG (mg/dL) 102.5 (88.0–125.0) 104.0 (89.0–124.0)
PG in 75-g OGTT at 120 min (mg/dL) 94.0 (87.0–102.0) 89.0 (84.0–96.0)
Fasting Insulin in 75-g OGTT (mg/dL) 9.0 (6.3–12.3) 7.6 (5.7–10.4)
Insulin in 75-g OGTT at 120 min (mg/dL) 42.9 (25.6–72.4) 44.9 (29.7–67.3)
Triglycerides (NR </= 200 mg/dL) 104 (77–143) 91 (73–119)
HDL cholesterol (NR male/female =/>  35/45 mg/dL) 53 (45–65) 70 (57–79)
LDL cholesterol (NR < 130 mg/dL) 122 (100–147) 136 (112–162)
Cholesterol (NR < 200 mg/dL) 201 (177–228) 232 (202–256)
Obesity [n, %] 28 (15.5) 49 (19.1)
T2D [n, %] 20 (11.0) 17 (6.6)
HOMA-IR > 1.9 [n, %] 21 (12.1) 22 (9.1)
ISIOGTT < 4 [n, %]a 51 (31.8) 65 (28.6)
CRP (NR < 5 mg/L) 1.2 (0.7–2.3) 1.2 (0.6–2.0)
Basophils (NR 0–0.2 G/L) 0.05 (0.05–0.05) 0.05 (0.05–0.05)
Eosinophils (NR 0.02–0.5 G/L) 0.18 (0.11–0.24) 0.15 (0.10–0.220)
Leukocytes (NR 3.9–10.5 G/L) 5.7 (4.7–6.7) 5.5 (4.6–6.4)
Monocytes (NR 0.1–0.9 G/L) 0.45 (0.36–0.53) 0.35 (0.29–0.43)
Neutrophils (NR 1.5–7.7 G/L) 3.2 (2.7–4.0) 3.1 (2.5–3.7)
  1. Categorical data are presented as percentages. None of the continuous variables were normally distributed; thus, values are presented as median and interquartile range. BMI body mass index, HOMA-IR homeostasis model assessment of insulin resistance. ISIOGTT insulin sensitivity index, NR normal range, OGTT oral glucose tolerance test, PG plasma glucose, T2D type 2 diabetes. aISIOGTT was not assessed for participants with type 2 diabetes